Polpharma Pursues Tysabri Through Antelope Trial

First Patients Recruited In Poland

 
• By Aidan Fry
Hunting
Polpharma Biologics is pursuing a biosimilar of Tysabri through its Antelope Phase III clinical study • Source: Shutterstock

More from Biosimilars

More from Products